Injectable cell-laden gelatin-chondroitin sulphate hydrogels for liver in vitro models

Liver extracellular matrix-based models that precisely reproduce liver physiology and functions are required as 3D culture microenvironments for multiple applications in toxicology and metabolism, or for understanding the mechanisms implicated in liver disease. We introduced injectable gelatin-chond...

Full description

Saved in:
Bibliographic Details
Published in:International journal of biological macromolecules 2024-12, Vol.288, p.138693, Article 138693
Main Authors: Sanchez-Gonzalez, E., Naranjo-Alcazar, R., Tort-Ausina, I., Donato, M.T., Salmeron-Sanchez, M., Tolosa, L., Gallego-Ferrer, G.
Format: Article
Language:English
Subjects:
3D culture
Chondroitin sulphate
Functionality
Gelatin
HepG2 cells
Hydrogel
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Liver extracellular matrix-based models that precisely reproduce liver physiology and functions are required as 3D culture microenvironments for multiple applications in toxicology and metabolism, or for understanding the mechanisms implicated in liver disease. We introduced injectable gelatin-chondroitin sulphate (Gel/CS) hydrogels for culturing HepG2 cells, and evaluated the mechanical properties and functionality of cells in different Gel/CS compositions. The Gel/CS hydrogels exhibited soft mechanical properties and allowed the HepG2 culture. The characterisation and comparison of 3D cultures to standard monolayer systems revealed the regulation of key hepatic markers (i.e. CYP3A4, GSTA1) when cells were cultured in the Gel/CS hydrogels compared to 2D cultures, and also enhanced urea and albumin production, which would indicate increased cells functionality. This study underpins 3D in vitro models based on the Gel/CS hydrogels that can be used for different hepatology applications by offering increased predictivity and physiological relevance compared to current in vitro models. [Display omitted]
ISSN:0141-8130
1879-0003
1879-0003
DOI:10.1016/j.ijbiomac.2024.138693